LEADER 01648oam  2200457 a 450 
001 9910699608003321
005 20110103143748.0
035   $a(CKB)5470000002404861
035   $a(OCoLC)672394995
035   $a(EXLCZ)995470000002404861
100   $a20101028d2010      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPay to delay$b[electronic resource] $eare patent settlements that delay generic drug market entry anticompetitive? : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, June 3, 2009
210  1$aWashington :$cU.S. G.P.O.,$d2010.
215   $a1 online resource (iii, 180 pages) $cillustrations
300   $aTitle from title screen (viewed on Oct. 28, 2010).
320   $aIncludes bibliographical references.
517   $aPay to delay 
606   $aPharmaceutical industry$zUnited States
606   $aCompetition
606   $aDrugs$xPrices$zUnited States
606   $aDrugs$zUnited States$vPatents
606   $aDrugs$xLaw and legislation$zUnited States
606   $aPatent laws and legislation$zUnited States
615  0$aPharmaceutical industry
615  0$aCompetition.
615  0$aDrugs$xPrices
615  0$aDrugs
615  0$aDrugs$xLaw and legislation
615  0$aPatent laws and legislation
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910699608003321
996   $aPay to delay$93543046
997   $aUNINA